ANOTHER hospital has been granted a compassionate special permit for the use of antiparasitic drug ivermectin as treatment for coronavirus disease 2019 (Covid-19).
In a virtual press briefing Friday, April 16, 2021, Food and Drug Administration (FDA) Director General Eric Domingo said the permit allows the hospital to secure one drug per 100 patients.
He said the two hospitals that were granted the permit are expected to closely monitor and regularly report on the status of their patients.
The two hospitals are also accountable for any adverse effects of the use of ivermectin.
Domingo did not name the two hospitals.
He reiterated that there have been no scientifically proven positive effects of ivermectin on Covid-19 patients.
"The conclusion, so far, by the experts is that there is insufficient evidence to recommend the use of ivermectin against Covid-19," said Domingo.
Ivermectin is approved in the Philippines as antiparasitic treatment for animals. It is not approved for commercial distribution as Covid-19 treatment. (HDT / SunStar Philippines)